menu
    • menu

    Company profile for Yisheng Biopharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Yisheng Biopharma is a global, fully integrated bio-pharmaceutical company.YishengBio is a global, fully integrated biopharmaceutical company headquartered in Beijing. The company is engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using novel PIKA® immunomodulating technology. YishengBio operates in China, USA, and Singapore with over 500 employees

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Yisheng BiopharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing Distri...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://yishengbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    YS Biopharma Announces Name Change to LakeShore Biopharma
    YS Biopharma Announces Name Change to LakeShore Biopharma

    24 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ys-biopharma-announces-name-change-to-lakeshore-biopharma-302155079.html

    PR NEWSWIRE
    24 May 2024
    Share Share
    YS Biopharma Announces Results of Extraordinary General Meeting
    YS Biopharma Announces Results of Extraordinary General Meeting

    21 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ys-biopharma-announces-results-of-extraordinary-general-meeting-302151701.html

    PR NEWSWIRE
    21 May 2024
    Share Share
    YS Biopharma EGM On May 21, Appoints Interim CEO
    YS Biopharma EGM On May 21, Appoints Interim CEO

    07 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ys-biopharma-to-hold-extraordinary-general-meeting-on-may-21-2024-and-announces-the-appointment-of-interim-chief-executive-officer-302138588.html

    PR NEWSWIRE
    07 May 2024
    Share Share
    YS Biopharma Gets 180 Day Nasdaq Extension for Minimum Bid Compliance
    YS Biopharma Gets 180 Day Nasdaq Extension for Minimum Bid Compliance

    29 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ys-biopharma-receives-additional-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-price-rule-302129986.html

    PR NEWSWIRE
    29 Apr 2024
    Share Share
    YS Biopharma Reports Unaudited First 9 Months FY2024 Financials
    YS Biopharma Reports Unaudited First 9 Months FY2024 Financials

    19 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ys-biopharma-announces-unaudited-financial-results-for-the-first-nine-months-of-fiscal-year-2024-302121952.html

    PR NEWSWIRE
    19 Apr 2024
    Share Share
    YS Biopharma Gets Phase 1 Trial Approval For HBV Vaccine
    YS Biopharma Gets Phase 1 Trial Approval For HBV Vaccine

    18 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ys-biopharma-granted-phase-i-clinical-trial-license-of-therapeutic-chronic-hepatitis-b-virus-vaccine-302120805.html

    PR NEWSWIRE
    18 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search